CLINICAL TRIALS PROFILE FOR IXABEPILONE
✉ Email this page to a colleague
All Clinical Trials for Ixabepilone
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00004927 ↗ | BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | Completed | Memorial Sloan Kettering Cancer Center | Phase 1 | 1999-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy. |
| NCT00004927 ↗ | BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | Completed | National Cancer Institute (NCI) | Phase 1 | 1999-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy. |
| NCT00004927 ↗ | BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | Completed | Bristol-Myers Squibb | Phase 1 | 1999-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy. |
| NCT00004927 ↗ | BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy | Completed | R-Pharm | Phase 1 | 1999-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have advanced solid tumors that have not responded to previous therapy. |
| NCT00005807 ↗ | Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer | Completed | National Cancer Institute (NCI) | Phase 1 | 2000-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have metastatic, recurrent, or locally advanced, ovarian cancer, breast cancer, or metastatic or unresectable solid tumors. |
| NCT00005807 ↗ | Treating Patients With Advanced Solid Tumors, Breast Cancer or Recurrent Ovarian Cancer | Completed | Albert Einstein College of Medicine | Phase 1 | 2000-07-01 | RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of BMS-247550 in treating patients who have metastatic, recurrent, or locally advanced, ovarian cancer, breast cancer, or metastatic or unresectable solid tumors. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Ixabepilone
Condition Name
Clinical Trial Locations for Ixabepilone
Trials by Country
Clinical Trial Progress for Ixabepilone
Clinical Trial Phase
Clinical Trial Sponsors for Ixabepilone
Sponsor Name
